Accuray Incorporated (LON:0H8I)
London · Delayed Price · Currency is GBP · Price in USD 1.631
+0.050 (3.16%)
At close: Sep 12, 2025
Accuray Market Cap
Accuray has a market cap or net worth of 130.54 million as of September 12, 2025. Its market cap has decreased by -22.20% in one year.
Market Cap
130.54M
Enterprise Value
218.33M
Revenue
334.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.63
Market Cap Chart
Since February 8, 2007, Accuray's market cap has decreased from 759.37M to 130.54M, a decrease of -82.81%. That is a compound annual growth rate of -9.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 131.99M | -17.01% |
| Dec 31, 2024 | 159.05M | -26.25% |
| Dec 29, 2023 | 215.67M | 32.58% |
| Dec 30, 2022 | 162.67M | -49.21% |
| Dec 31, 2021 | 320.28M | 14.89% |
| Dec 31, 2020 | 278.77M | 47.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 184.75B |
| GSK plc | 59.92B |
| Haleon | 32.68B |
| Smith & Nephew | 12.36B |
| ConvaTec Group | 4.79B |
| Hikma Pharmaceuticals | 3.68B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.76B |